CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis

Lu Han; De-Jun Cui; Bo Huang; Qian Yang; Tao Huang; Guo-Yuan Lin; Shao-Jie Chen

doi:doi:10.18632/aging.204776

← Back

Research Paper Volume 15, Issue 11 pp 5032—5051

CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis

Figure 8. The association between CLDN5 among TMB levels (A) and MSI (B). (C–E) KEGG, Hallmark, and Go analysis of CLDN5 in STAD. (C) KEGG analysis of CLDN5 in STAD. (D) Hallmark analysis of CLDN5 in STAD. (E) GO analysis of CLDN5 in STAD.